Terms: = Lymphoma AND CTCF, P49711, 10664, ENSG00000102974
52 results:
1. DARDN: A Deep-Learning Approach for ctcf Binding Sequence Classification and Oncogenic Regulatory Feature Discovery.
Cho HJ; Wang Z; Cong Y; Bekiranov S; Zhang A; Zang C
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397134
[TBL] [Abstract] [Full Text] [Related]
2. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent ctcf inactivating mutations in acute T cell leukemia.
Smits WK; Vermeulen C; Hagelaar R; Kimura S; Vroegindeweij EM; Buijs-Gladdines JGCAM; van de Geer E; Verstegen MJAM; Splinter E; van Reijmersdal SV; Buijs A; Galjart N; van Eyndhoven W; van Min M; Kuiper R; Kemmeren P; Mullighan CG; de Laat W; Meijerink JPP
Cell Rep; 2023 Apr; 42(4):112373. PubMed ID: 37060567
[TBL] [Abstract] [Full Text] [Related]
3. Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at ctcf Binding Sites on the Viral Genome.
Dunn LEM; Lu F; Su C; Lieberman PM; Baines JD
J Virol; 2023 Feb; 97(2):e0189422. PubMed ID: 36744959
[TBL] [Abstract] [Full Text] [Related]
4. Population-based targeted RNA sequencing reveals novel disease-related gene fusions in pediatric and adult T-ALL.
Norvilas R; Batiuskaite R; Dirse V; Semaskeviciene R; Gineikiene E; Stoskus M; Vaitkeviciene G; Rascon J; Griskevicius L
Leuk Res; 2022 May; 116():106825. PubMed ID: 35339799
[TBL] [Abstract] [Full Text] [Related]
5. Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes.
Studd JB; Cornish AJ; Hoang PH; Law P; Kinnersley B; Houlston R
Blood Cancer J; 2021 Nov; 11(11):177. PubMed ID: 34753926
[TBL] [Abstract] [Full Text] [Related]
6. The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study.
Zhou B; Chu X; Tian H; Liu T; Liu H; Gao W; Chen S; Hu S; Wu D; Xu Y
Am J Hematol; 2021 Nov; 96(11):1461-1471. PubMed ID: 34406703
[TBL] [Abstract] [Full Text] [Related]
7. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.
Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS
Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366
[TBL] [Abstract] [Full Text] [Related]
8. Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X.
Liu Y; Li C; Shen S; Chen X; Szlachta K; Edmonson MN; Shao Y; Ma X; Hyle J; Wright S; Ju B; Rusch MC; Liu Y; Li B; Macias M; Tian L; Easton J; Qian M; Yang JJ; Hu S; Look AT; Zhang J
Nat Genet; 2020 Aug; 52(8):811-818. PubMed ID: 32632335
[TBL] [Abstract] [Full Text] [Related]
9. DeepMILO: a deep learning approach to predict the impact of non-coding sequence variants on 3D chromatin structure.
Trieu T; Martinez-Fundichely A; Khurana E
Genome Biol; 2020 Mar; 21(1):79. PubMed ID: 32216817
[TBL] [Abstract] [Full Text] [Related]
10. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia.
Kloetgen A; Thandapani P; Ntziachristos P; Ghebrechristos Y; Nomikou S; Lazaris C; Chen X; Hu H; Bakogianni S; Wang J; Fu Y; Boccalatte F; Zhong H; Paietta E; Trimarchi T; Zhu Y; Van Vlierberghe P; Inghirami GG; Lionnet T; Aifantis I; Tsirigos A
Nat Genet; 2020 Apr; 52(4):388-400. PubMed ID: 32203470
[TBL] [Abstract] [Full Text] [Related]
11. Alteration of ctcf-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
[TBL] [Abstract] [Full Text] [Related]
12. HTLV-1 ctcf-binding site is dispensable for in vitro immortalization and persistent infection in vivo.
Martinez MP; Cheng X; Joseph A; Al-Saleem J; Panfil AR; Palettas M; Dirksen WP; Ratner L; Green PL
Retrovirology; 2019 Dec; 16(1):44. PubMed ID: 31864373
[TBL] [Abstract] [Full Text] [Related]
13. A super enhancer controls expression and chromatin architecture within the MHC class II locus.
Majumder P; Lee JT; Rahmberg AR; Kumar G; Mi T; Scharer CD; Boss JM
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31753848
[TBL] [Abstract] [Full Text] [Related]
14. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
[TBL] [Abstract] [Full Text] [Related]
15. The whole-genome landscape of Burkitt lymphoma subtypes.
Panea RI; Love CL; Shingleton JR; Reddy A; Bailey JA; Moormann AM; Otieno JA; Ong'echa JM; Oduor CI; Schroeder KMS; Masalu N; Chao NJ; Agajanian M; Major MB; Fedoriw Y; Richards KL; Rymkiewicz G; Miles RR; Alobeid B; Bhagat G; Flowers CR; Ondrejka SL; Hsi ED; Choi WWL; Au-Yeung RKH; Hartmann W; Lenz G; Meyerson H; Lin YY; Zhuang Y; Luftig MA; Waldrop A; Dave T; Thakkar D; Sahay H; Li G; Palus BC; Seshadri V; Kim SY; Gascoyne RD; Levy S; Mukhopadyay M; Dunson DB; Dave SS
Blood; 2019 Nov; 134(19):1598-1607. PubMed ID: 31558468
[TBL] [Abstract] [Full Text] [Related]
16. BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells.
Debruyne DN; Dries R; Sengupta S; Seruggia D; Gao Y; Sharma B; Huang H; Moreau L; McLane M; Day DS; Marco E; Chen T; Gray NS; Wong KK; Orkin SH; Yuan GC; Young RA; George RE
Nature; 2019 Aug; 572(7771):676-680. PubMed ID: 31391581
[TBL] [Abstract] [Full Text] [Related]
17. Noncoding RNA transcription at enhancers and genome folding in cancer.
Isoda T; Morio T; Takagi M
Cancer Sci; 2019 Aug; 110(8):2328-2336. PubMed ID: 31228211
[TBL] [Abstract] [Full Text] [Related]
18. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
19. Acute depletion of ctcf directly affects MYC regulation through loss of enhancer-promoter looping.
Hyle J; Zhang Y; Wright S; Xu B; Shao Y; Easton J; Tian L; Feng R; Xu P; Li C
Nucleic Acids Res; 2019 Jul; 47(13):6699-6713. PubMed ID: 31127282
[TBL] [Abstract] [Full Text] [Related]
20. Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia.
Yang M; Vesterlund M; Siavelis I; Moura-Castro LH; Castor A; Fioretos T; Jafari R; Lilljebjörn H; Odom DT; Olsson L; Ravi N; Woodward EL; Harewood L; Lehtiö J; Paulsson K
Nat Commun; 2019 Apr; 10(1):1519. PubMed ID: 30944321
[TBL] [Abstract] [Full Text] [Related]
[Next]
